Table 1

Average annual trends in the numbers of in-patient treatment of warts with summary rate ratios, 2000–2011
Pre-vaccine period Vaccine period Pre-vaccine vs vaccine period
Average annual trend 95% CI p-value Average annual trend 95% CI p-value Summary rate ratio 95% CI p-value
Female – vulval/vaginal
15-24 years 1.00 0.99 - 1.01 0.556 0.76 0.73 - 0.79 <0.001 0.33 0.30 - 0.37 <0.001
25-34 years 0.98 0.97 - 0.99 0.001 0.93 0.90 - 0.97 <0.001 0.60 0.54 - 0.66 <0.001
35-44 years 0.99 0.97 - 1.00 0.116 1.03 0.99 - 1.07 0.115 0.91 0.81 - 1.03 0.145
Male – penile
15-24 years 1.1 1.04 - 1.1 <0.001 0.86 0.80 - 0.93 <0.001 0.76 0.62 - 0.96 0.022
25-34 years 0.98 0.95 - 1.01 0.144 0.90 0.84 - 0.96 0.001 0.81 0.66 - 0.99 0.040
35-44 years 0.97 0.93 - 1.01 0.125 0.93 0.84 - 1.03 0.161 0.70 0.51 - 0.95 0.024
Male – anal
15-24 years 1.08 1.03 - 1.14 0.003 0.90 0.81 - 1.00 0.055 0.92 0.77 - 1.10 0.370
25-34 years 0.97 0.94 - 1.01 0.143 0.95 0.87 - 1.04 0.241 0.69 0.59 - 0.79 <0.001
35-44 years 0.99 0.95 - 1.03 0.559 0.91 0.83 - 0.99 0.027 0.86 0.74 - 0.99 0.036

CI = confidence interval.

Ali et al.

Ali et al. BMC Infectious Diseases 2013 13:140   doi:10.1186/1471-2334-13-140

Open Data